Multi-source data-driven machine learning reshapes the diagnosis and treatment of lung cancer
Peer-Reviewed Publication
Updates every hour. Last Updated: 25-Oct-2026 05:16 ET (25-Oct-2026 09:16 GMT/UTC)
This review explores how multi-source data-driven machine learning is transforming lung cancer care, from early screening and diagnosis to personalized treatment and prognosis. It examines imaging, multi-omics, liquid biopsy, pathology, and clinical data, alongside traditional and advanced machine learning approaches. By linking data characteristics with model selection and clinical applications, the review highlights opportunities for precision medicine while addressing challenges in data standardization, multimodal integration, interpretability, and effective clinical translation.
Worcester Polytechnic Institute researcher Catherine Whittington is launching a new project to develop laboratory models for the study of uterine fibroids, and before work had even begun, WPI students had already played a critical role.
UC San Diego has launched Brain-FRAMe, an innovative program integrating neuroscience and immunology to improve brain health and clinical care for people living with HIV and methamphetamine use disorder.
Wastewater and environmental surveillance (WES) – the analysis of water and environmental samples like sewage to enable early, non-invasive tracking of biological and chemical markers across a population – is a powerful and increasingly common public health tool. When paired with clinical data, it offers a real-time window into community health that can inform faster, more targeted responses to infectious disease. However, its use in carceral settings like jails and prisons remains ethically underexamined.
In a brief analytic essay in the American Journal of Public Health, a team comprised of Boston University and University of Louisville researchers found that carceral WES is neither fully covered by human subjects protections nor fully accountable to traditional public health guidelines, producing a fragmented regulatory landscape in which some safeguards impede informed and effective research while others fail to prevent misuse or harm to incarcerated individuals and surrounding communities.
Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage drug discovery company powered by generative artificial intelligence (AI), announced that it will be included in MSCI Global Small Cap Indexes compiled by Morgan Stanley Capital International (MSCI). The change will take effect as of the close of August 31, 2026.
A new review from Hasanuddin University highlights how chitosan and alginate-based composite beads could be the next-generation solution for sustainable wastewater remediation. By combining naturally derived biopolymers with functional additives, these composite beads demonstrate improved adsorption capacity, mechanical stability, reusability, and stronger pollutant binding. The review outlines a roadmap for advancing such composites into stimuli-responsive smart materials and extending their applications beyond water treatment to circular bioeconomy, smart agriculture, and even precision medicine.